Phone:
+1 877 302 8632
Fax:
+1 888 205 9894 (Toll-free)
E-Mail:
orders@antibodies-online.com

IDO1 antibody

Rockland 210-301-e58 IDO1 Reactivity: Mouse WB, ELISA, IHC, IF, FACS, IP, FM, MA Host: Mouse Monoclonal 2E2-6 unconjugated
Rockland
Catalog No. ABIN1043819
Supplier Product No.: 210-301-e58
  • Target See all IDO1 Antibodies
    IDO1 (Indoleamine 2,3-Dioxygenase 1 (IDO1))
    Reactivity
    • 72
    • 31
    • 16
    • 9
    • 1
    • 1
    • 1
    Mouse
    Host
    • 66
    • 11
    • 1
    • 1
    Mouse
    Clonality
    • 63
    • 16
    • 1
    Monoclonal
    Conjugate
    • 51
    • 5
    • 4
    • 2
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    This IDO1 antibody is un-conjugated
    Application
    • 63
    • 34
    • 23
    • 17
    • 17
    • 15
    • 14
    • 8
    • 6
    • 6
    • 2
    • 2
    • 1
    • 1
    • 1
    Western Blotting (WB), ELISA, Immunohistochemistry (IHC), Immunofluorescence (IF), Flow Cytometry (FACS), Immunoprecipitation (IP), Fluorescence Microscopy (FM), Multiplex Assay (MA)
    Supplier Product No.
    210-301-e58
    Supplier
    Rockland
    Purpose
    IDO1 Antibody
    Cross-Reactivity (Details)
    IDO1 antibody is specific for mouse IDO1 protein.
    Characteristics
    Synonyms: mouse anti-IDO1 antibody, Ido, Indo, Indoleamine 2,3-dioxygenase 1, Indoleamine-pyrrole 2,3-dioxygenase, Ido 1, Ido-1, IDO1 antibody, mouse anti-IDO-1 antibody
    Purification
    Anti-IDO1 antibody was purified from ascites fluid by Protein A chromatography followed by extensive dialysis against the buffer stated above.
    Sterility
    Sterile filtered
    Immunogen

    Immunogen: IDO1 antibody was produced in mouse by repeated immunizations with mouse recombinant IDO1 protein followed by hybridoma development.

    Immunogen Type: Recombinant Protein

    Clone
    2E2-6
    Isotype
    IgG1
    Top Product
    Discover our top product IDO1 Primary Antibody
  • Application Notes

    Flow Cytometry Dilution: 0.5-1x10^6 cells

    Immunohistochemistry Dilution: User Optimized

    Application Note: Anti-IDO1 antibody has been tested for use in ELISA, Western Blot, IF, IHC, and Flow Cytometry. Specific conditions for reactivity should be optimized by the end user.

    Western Blot Dilution: 1:500-1:1500

    Immunoprecipitation Dilution: 10-100 μL

    ELISA Dilution: 1:5000-1:50000

    IF Microscopy Dilution: 1:50-1:100

    Restrictions
    For Research Use only
  • Format
    Liquid
    Concentration
    0.95 mg/mL
    Buffer

    Buffer: 0.02 M Potassium Phosphate, 0.15 M Sodium Chloride, pH 7.2

    Stabilizer: None

    Preservative: 0.01 % (w/v) Sodium Azide
    Preservative
    Sodium azide
    Precaution of Use
    This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
    Storage
    4 °C,-20 °C
    Storage Comment
    Store vial at -20° C prior to opening. Aliquot contents and freeze at -20° C or below for extended storage. Avoid cycles of freezing and thawing. Centrifuge product if not completely clear after standing at room temperature. This product is stable for several weeks at 4° C as an undiluted liquid. Dilute only prior to immediate use.
    Expiry Date
    12 months
  • Mellor, Munn: "IDO expression by dendritic cells: tolerance and tryptophan catabolism." in: Nature reviews. Immunology, Vol. 4, Issue 10, pp. 762-74, (2004) (PubMed).

  • Target
    IDO1 (Indoleamine 2,3-Dioxygenase 1 (IDO1))
    Alternative Name
    Ido1 (IDO1 Products)
    Background
    Background: Anti-IDO-1 antibody recognizes indoleamine 2, 3-dioxygenase1 (IDO1) is a 41-42 kD intracellular enzyme that catabolizes tryptophan into kynurenine. IDO1 modulates levels of the amino acid tryptophan, which is vital for cell growth, but is also involved in the suppression of the immune response. IDO1 effects on immune suppression are due to decreased tryptophan availability and the generation of tryptophan metabolites, resulting in negative effects on T lymphocytes, including proliferation, function and survival. IDO1 may be involved in the suppression of the immune response to tumors, and blocking the IDO1 pathway may be a potential target for immuno and cancer therapy. IDO1 is expressed in a wide variety of tissues and can be upregulated by interferon gamma and other inflammatory cytokines.
    Gene ID
    15930
    NCBI Accession
    NP_032350
    UniProt
    P28776
    Pathways
    Activated T Cell Proliferation
You are here:
Support